Aprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway

dc.contributor.authorAlfatli, Layla Ameen Rasheed
dc.contributor.authorTweij, Thu-Alfeqar R.
dc.date.accessioned2026-02-12T20:29:17Z
dc.date.available2026-02-12T20:29:17Z
dc.date.issued2025-12
dc.descriptionEthical approval for the experiments in this study was obtained from the Ethics Committee of the Faculty of Pharmacy, University of Kufa, Najaf, Iraq (Approval No. 3177/2025-2-4).
dc.description.abstractIntroduction and aim. Renal ischemia-reperfusion (I/R) injury is a primary cause of acute kidney injury (AKI). The NF-κB/NLRP3/caspase-1 signaling system is crucial for I/R-induced kidney damage, which leads to inflammation, pyroptosis, and tissue damage. Aprocitentan has anti-inflammatory and vasoprotective properties, suggesting its potential nephroprotective advantages. The aim of this investigation was to evaluate the protective advantages of aprocitentan against renal I/R injury in rat models. This was achieved by evaluating the impact of aprocitentan on inflammation, pyroptosis, and kidney function by altering the NF-κB/NLRP3/Caspase-1 pathway. Material and methods. Using twenty-four adult male Sprague-Dawley rats, four separate groups were formed: sham group, I/R control group, dimethyl sulfoxide group (DMSO) and aprocitentan group (10 mg/kg). Renal ischemia/reperfusion was induced by a period of forty minutes of bilateral ischemia, which was followed by two hours of reperfusion. To evaluate the renoprotective effect of aprocitentan urea, creatinine, neutrophil gelatinase-associated lipocalin (NGAL), phosphorylated nuclear factor kappa B p65 (NF-κB p65), NOD-like receptor protein 3 (NLRP3), and cysteine-aspartic protease-1 (caspase-1), were measured, along with histopathological examination. Results. Compared to the sham group, the I/R control group had significantly increased concentrations of urea, creatinine, NGAL, NF-κB p65, NLRP3, as well as caspase-1. These signs decreased in the aprocitentan group, leading to enhanced renal function, reduction of inflammation, and inhibition of pyroptosis. Histology showed a decrease in tubular inflammation and necrosis in the aprocitentan group. Conclusion. Aprocitentan decreases inflammation and inhibits pyroptosis by suppressing the NF-κB/NLRP3/Caspase-1 pathway. These results illustrate its promising potential to prevent ischemic renal diseases, including acute kidney injury.eng
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 23, z. 4 (2025), s. 936–946
dc.identifier.doi10.15584/ejcem.2025.4.13
dc.identifier.issn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/12197
dc.language.isoeng
dc.publisherRzeszów University Press
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectacute kidney injury
dc.subjectcaspase-1
dc.subjectendothelin receptor antagonist
dc.subjectischemia-reperfusion
dc.subjectpyroptosis
dc.subjectNLRP3 inflammasome
dc.titleAprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway
dc.typearticle

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
12.Aprocitentan+mitigates+ischemia+reperfusion+induced+kidney.pdf
Rozmiar:
1.3 MB
Format:
Adobe Portable Document Format

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis: